3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats

Thyroid hormone mimetics are alluring potential therapies for diseases like dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and insulin resistance. Though diiodothyronines are thought inactive, pharmacologic treatment with 3,5- Diiodo-L-Thyronine (T2) reportedly reduces hepatic lipid content...

Descripción completa

Detalles Bibliográficos
Autores principales: Vatner, Daniel F., Snikeris, Jaclyn, Popov, Violeta, Perry, Rachel J., Rahimi, Yasmeen, Samuel, Varman T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618341/
https://www.ncbi.nlm.nih.gov/pubmed/26485433
http://dx.doi.org/10.1371/journal.pone.0140837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618341/
https://www.ncbi.nlm.nih.gov/pubmed/26485433
http://dx.doi.org/10.1371/journal.pone.0140837

Ejemplares similares